Recently, there has been a deluge of research and news surrounding e-cigarettes and vaping – particularly regarding adolescent usage. Join us as we discuss a recent study describing the prevalence of cannabis use in e-Cigarettes and some strategies for addressing this in your practice.

Keeping up with the many new drugs approved for use in the U.S. each year is a constant challenge. However, only a small number of new drugs each year are novel, work by a new mechanism, and are relevant for primary care practice. This talk will provide a balanced evaluation of these important novel drugs and address efficacy, side effects, cost, and the impact on primary care practice.

In this informative session, the speaker will help clinicians build better understandings with their patients and discuss how to make the office a more welcoming environment. Participants will walk away with culturally informed and sensitive approaches to counseling and an enhanced comprehension of the unique mental health problems faced by the LGBTQ population.

Listen as expert Pri-Med faculty Dr. Ty Gluckman summarizes major take-home points about real work evidence and the impact of real word evidence on NOAC therapy for stroke prevention for patients with atrial fibrillation.

Cannabinoids include tetrahydrocannabinol (THC) and cannabidiol, which are found in marijuana, as well as synthetic compounds such as nabilone. The agents have been studied for the treatment of various chronic pain conditions. A meta-analysis was performed that analyzed any cannabinoid, for any chronic pain condition.

Health benefits and the potential lowering of healthcare costs by billions of dollars seem like enough reasons to increase physical activity. Why can’t we do it? Why is it so hard? We’ll discuss the new guidelines (11/2018) and strategies that may get your patients moving.